Literature DB >> 22300047

Recent progress in understanding of structure, ligand interactions and the mechanism of activation of the β₂-adrenergic receptor.

M Kolinski1, A Plazinska, K Jozwiak.   

Abstract

The understanding of β₂-adrenergic receptor (β₂AR) interactions with ligands as well as the mechanism of receptor activation changed radically from 2007, when the first crystallographic structure of the receptor was reported. Since then numerous crystallographic studies described interactions with all main classes of β₂AR ligands and with G proteins, which provided a great insight into the molecular structure of the receptor. However, molecular mechanisms of receptor activations remain to be determined. Functional research supported the concept of ligand-directed signaling at β-adrenoceptors. Agonist can activate alternative signaling pathways with different capacities and trigger cellular effects. It indicates that agonists nominally belonging to the same class may bind to and/or stabilize different active conformations of the receptor which are selectively recognized by signaling proteins in the allosteric manner.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300047     DOI: 10.2174/092986712799320547

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  9 in total

1.  G Protein-Coupled Estrogen Receptor (GPER) Agonist Dual Binding Mode Analyses toward Understanding of its Activation Mechanism: A Comparative Homology Modeling Approach.

Authors:  Christopher K Arnatt; Yan Zhang
Journal:  Mol Inform       Date:  2013-07       Impact factor: 3.353

2.  Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease.

Authors:  Caterina Branca; Elena V Wisely; Lauren K Hartman; Antonella Caccamo; Salvatore Oddo
Journal:  Neurobiol Aging       Date:  2014-06-16       Impact factor: 4.673

3.  Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.

Authors:  Elena V Wisely; Yang K Xiang; Salvatore Oddo
Journal:  Hum Mol Genet       Date:  2014-03-13       Impact factor: 6.150

4.  Bioinformatics and computational biology in Poland.

Authors:  Janusz M Bujnicki; Jerzy Tiuryn
Journal:  PLoS Comput Biol       Date:  2013-05-02       Impact factor: 4.475

5.  Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors.

Authors:  Ann M Ferrie; Haiyan Sun; Natalya Zaytseva; Ye Fang
Journal:  Sci Rep       Date:  2014-01-23       Impact factor: 4.379

6.  Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.

Authors:  Anita Plazinska; Wojciech Plazinski; Krzysztof Jozwiak
Journal:  Eur Biophys J       Date:  2015-03-01       Impact factor: 1.733

7.  Spatiotemporal Changes in the Gene Expression Spectrum of the β2 Adrenergic Receptor Signaling Pathway in the Lungs of Rhesus Monkeys.

Authors:  Zhongmei Zheng; Bangrong Cao; Yu Hu; Liang Xie; Ling Gu; Fang Shi; Hanmin Liu
Journal:  Lung       Date:  2021-01-29       Impact factor: 2.584

Review 8.  Structural Insights into Ligand-Receptor Interactions Involved in Biased Agonism of G-Protein Coupled Receptors.

Authors:  Krzysztof Jóźwiak; Anita Płazińska
Journal:  Molecules       Date:  2021-02-06       Impact factor: 4.411

9.  Norepinephrine and Epinephrine Enhanced the Infectivity of Enterovirus 71.

Authors:  Yu-Ting Liao; Shih-Min Wang; Jen-Ren Wang; Chun-Keung Yu; Ching-Chuan Liu
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.